Structures by: Domasevitch K. V.
Total: 314
Co (H C O O)2 (H C O N H2)2
C4H4CoN2O6
Zeitschrift fuer Anorganische und Allgemeine Chemie (2002) 628, 51-56
a=12.7589Å b=8.25Å c=8.1893Å
α=90° β=92.643° γ=90°
Molybdenum(VI) oxide 2:1 complex with 1,2-bis(1,2,4-triazol-4- yl)ethane
C12H16Mo4N12O12
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=15.2779(16)Å b=12.6491(13)Å c=12.1712(11)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 2:1 complex with 1,3-bis(1,2,4-triazol-4- yl)propane
C7H10Mo2N6O6
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=9.4050(4)Å b=11.7467(5)Å c=11.9594(5)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 2:1 complex with trans-1,4-bis(1,2,4- triazol-4-yl)cyclohexane
C10H14Mo2N6O6
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=12.0221(7)Å b=13.0629(8)Å c=19.4476(16)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 2:1 complex with 1,3-bis(1,2,4-triazol-4- yl)adamantane Hexahydrate
C14H18Mo2N6O6,6(H2O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=15.1155(9)Å b=12.4471(7)Å c=12.4209(9)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 2:1 complex with 4,9-bis(1,2,4-triazol-4- yl)diamantane Semihydrate
C18H22Mo2N6O6,0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=12.4256(9)Å b=16.6809(16)Å c=10.4993(10)Å
α=90.00° β=90.00° γ=90.00°
Molybdenum(VI) oxide 4:1 complex with 1,6-bis(1,2,4-triazol-4- yl)diamantane Dihydrate
C18H22N6,4(MoO3),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=7.3804(8)Å b=7.5670(10)Å c=11.5827(14)Å
α=85.928(12)° β=86.074(10)° γ=89.873(11)°
Molybdenum(VI) oxide complex with 5-(4-(1,2,4-triazol-4- yl)phenyl)tetrazole
C9H7MoN7O3
Dalton transactions (Cambridge, England : 2003) (2010) 39, 17 4223-4231
a=19.5123(11)Å b=19.5123(11)Å c=11.9438(7)Å
α=90.00° β=90.00° γ=90.00°
3-Nitro-4,4'-bipyrazole
C6H5N5O2
New Journal of Chemistry (2018)
a=5.4831(2)Å b=5.4831(2)Å c=47.463(3)Å
α=90° β=90° γ=90°
3,3'-Dinitro-4,4'-bipyrazole
C6H4N6O4
New Journal of Chemistry (2018)
a=15.9744(9)Å b=6.5428(8)Å c=8.9414(8)Å
α=90° β=118.739(10)° γ=90°
3,3',5,5'-Tetranitro-4,4'-bipyrazole
C6H2N8O8
New Journal of Chemistry (2018)
a=16.4281(13)Å b=16.4281(13)Å c=8.3705(6)Å
α=90° β=90° γ=90°
3,5-Dinitro-4,4'-bipyrazole
C6H4N6O4
New Journal of Chemistry (2018)
a=6.1653(7)Å b=15.7789(12)Å c=8.7387(10)Å
α=90° β=107.434(10)° γ=90°
3,3',5,5'-Tetranitro-4,4'-bipyrazole Hydrate
C6H2N8O8,H2O
New Journal of Chemistry (2018)
a=11.1017(9)Å b=13.9227(10)Å c=8.2166(8)Å
α=90° β=110.654(10)° γ=90°
3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl 1:1 complex with Resorcinol
C16H20N4O2
New Journal of Chemistry (2004) 28, 6 756
a=18.270(3)Å b=8.5281(11)Å c=21.054(4)Å
α=90.00° β=90.00° γ=90.00°
3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl 2:1 adduct with Floroglucine, Monohydrate
C26H36N8O4
New Journal of Chemistry (2004) 28, 6 756
a=29.564(3)Å b=46.197(6)Å c=8.5541(10)Å
α=90.00° β=90.00° γ=90.00°
3,3',5,5'-tetramethyl-4,4'-bipyrazole 1:1 adduct with hydroquinone
C16H20N4O2
New Journal of Chemistry (2004) 28, 6 756
a=7.3717(7)Å b=14.1921(14)Å c=16.4357(16)Å
α=98.782(2)° β=94.460(2)° γ=103.055(2)°
3,5-dimethylpyrazole 1:1 adduct with phenol
C11H14N2O
New Journal of Chemistry (2004) 28, 6 756
a=8.0430(10)Å b=15.1160(12)Å c=8.9340(11)Å
α=90.00° β=96.650(12)° γ=90.00°
3,5-dimetylpyrazole 1:1 adduct with hydroquinone
C11H14N2O2
New Journal of Chemistry (2004) 28, 6 756
a=11.901(2)Å b=9.9022(19)Å c=18.667(4)Å
α=90.00° β=90.00° γ=90.00°
3,3',5,5'-tetramethyl-4,4'-bipyrazole 1:2 adduct with phenol
C22H26N4O2
New Journal of Chemistry (2004) 28, 6 756
a=19.065(2)Å b=14.725(2)Å c=8.5830(10)Å
α=90.00° β=114.80(2)° γ=90.00°
Copper(I) Tetrafluoroborate 4:5 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 4 Chloroform
C74H54B4Cl12Cu4F16N20
New Journal of Chemistry (2008) 32, 11 1910
a=12.5703(9)Å b=13.7895(13)Å c=14.1629(12)Å
α=94.203(11)° β=93.205(11)° γ=107.835(10)°
Copper(I) Dithionate bis(Acetonitrile) complex with 1,4-bi(pyridazin-4-yl)benzene
C18H16Cu2N6O6S2
New Journal of Chemistry (2008) 32, 11 1910
a=9.3471(6)Å b=18.9283(11)Å c=12.4791(9)Å
α=90.00° β=101.718(8)° γ=90.00°
Silver(I) nitrate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Chloroform solvate
C15H11AgCl3N5O3
New Journal of Chemistry (2008) 32, 11 1910
a=8.3964(2)Å b=9.5399(2)Å c=12.4383(3)Å
α=80.0473(10)° β=82.901(2)° γ=64.9520(11)°
Silver(I) Trifluoroacetate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, Acetonitrile solvate
C52H33Ag4F12N13O8
New Journal of Chemistry (2008) 32, 11 1910
a=10.9059(10)Å b=11.1531(11)Å c=13.8012(13)Å
α=92.620(11)° β=108.916(11)° γ=117.522(10)°
Silver(I) Methanesulfonate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 2 Chloroform
C48H44Ag4Cl6N12O12S4
New Journal of Chemistry (2008) 32, 11 1910
a=19.3101(19)Å b=17.3714(15)Å c=18.1903(15)Å
α=90.00° β=99.346(5)° γ=90.00°
Silver(I) Isophthalate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C66H62Ag6N12O22
New Journal of Chemistry (2008) 32, 11 1910
a=9.4238(6)Å b=14.2038(12)Å c=14.2032(10)Å
α=104.457(8)° β=98.140(8)° γ=108.924(9)°
Henicosa-[μ~3~-oxido]-nonadeca-[μ~3~-hydroxido]-octa-[μ-hydroxido]-tetraicosa-[μ-formiato-κ^2^O1:O2]-tetra-[formiato-κ^2^O1:O2]-hepta-[formiato-κO]-pentaaqua-hexaicosazirconium(IV) penta-formic acid solvate pentadecahydrate
C35H72O123Zr26,5(CH2O2)[solvent]
CrystEngComm (2018) 20, 35 5132
a=11.4132(8)Å b=18.7392(12)Å c=19.1989(11)Å
α=71.434(5)° β=73.347(5)° γ=81.818(5)°
Bis(4,4'-bipyridine)dinitratonickel(II) 1:2 complex with pyrene
C52H36N6NiO6
Chemical Communications (1999) 14 1327
a=11.3602(6)Å b=22.7707(13)Å c=15.8580(9)Å
α=90.00° β=93.9560(10)° γ=90.00°
3,3',5,5'-tetramethyl-4,4'-bipyrazole Chloroform solvate
C11H15Cl3N4
Chemical Communications (Cambridge, United Kingdom) (2003) 6 740-741
a=29.196(2)Å b=29.196(2)Å c=22.406(2)Å
α=90.00° β=90.00° γ=90.00°
3,3',5,5'-Tetramethyl-4,4'-Bipyrazole, Tetragonal form (
C10H14N4
Chemical Communications (Cambridge, United Kingdom) (2003) 6 740-741
a=27.619(3)Å b=27.619(3)Å c=8.6029(11)Å
α=90.00° β=90.00° γ=90.00°
3,3',5,5'-Tetramethyl-4,4'-Bipyrazole, Methanol solvate
C31H46N12O
Chemical Communications (Cambridge, United Kingdom) (2003) 6 740-741
a=26.1826(13)Å b=9.6386(4)Å c=27.420(2)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(3,3',5,5'-tetramethyl-4,4'-bipyrazolyl) Sulfato Diperchlorato Dicobalt(II), trihydrate
C40H62Cl2Co2N15O16S
Chemical Communications (2002) 5 436
a=13.7588(9)Å b=13.7588(9)Å c=16.7261(14)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl) Sulfato Dinitrato Dinickel(II), trihydrate
C40H62N18Ni2O13S
Chemical Communications (2002) 5 436
a=13.6542(13)Å b=13.6542(13)Å c=16.477(2)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(3,3',5,5'-Tetramethyl-4,4'-Bipyrazolyl) Sulfato Bis(thiocyanato) Dicobalt(II), Bis(Methanol) Bis(Chloroform) Solvate
C46H66Cl6Co2N18O6S3
Chemical Communications (2002) 5 436
a=13.699(2)Å b=21.594(3)Å c=22.220(3)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl) Sulfato Bis(thiocyanato) Dinickel(II), Bis(methanol) Bis(chloroform) Solvate
C46H66Cl6N18Ni2O6S3
Chemical Communications (2002) 5 436
a=13.6250(14)Å b=21.376(2)Å c=22.072(2)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Fluorophosphate 1:3 Complex with 1,4-bi(1,2,4- triazol-4-yl)benzene
C30H24CuN18,(FO3P)
CrystEngComm (2008) 10, 9 1216
a=16.0657(11)Å b=16.0657(11)Å c=7.7720(4)Å
α=90.00° β=90.00° γ=120.00°
Copper(ii) Nitrate 2:5 Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Dihydrate
C50H40Cu2N30,4(NO3),2(H2O)
CrystEngComm (2008) 10, 9 1216
a=24.6600(18)Å b=15.8459(8)Å c=7.7808(5)Å
α=90.00° β=95.485(8)° γ=90.00°
Copper(ii) Chloride 1:2 Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Dodecahydrate
C20H40Cl2CuN12O12
CrystEngComm (2008) 10, 9 1216
a=28.331(3)Å b=16.1470(12)Å c=7.1760(9)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Bromide 1:2 Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Dodecahydrate
(C20H16BrCuN12),Br,12(H2O)
CrystEngComm (2008) 10, 9 1216
a=28.449(3)Å b=15.7732(17)Å c=7.2593(7)Å
α=90.00° β=90.00° γ=90.00°
Dihydroxo Tetracopper(ii) Triflate Complex with 1,4-bi(1,2,4- triazol-4-yl)benzene, Dodecahydrate
C56H66Cu4F18N30O32S6
CrystEngComm (2008) 10, 9 1216
a=13.3427(11)Å b=13.4047(12)Å c=13.5620(12)Å
α=102.339(2)° β=104.3690(10)° γ=90.4770(10)°
Copper(ii) Sulfate Complex with 1,4-bi(1,2,4-triazol-4- yl)benzene, Hexahydrate
C10H20CuN6O10S
CrystEngComm (2008) 10, 9 1216
a=7.1442(4)Å b=19.4387(15)Å c=17.3114(12)Å
α=90.00° β=90.00° γ=90.00°
Tris(5-(4-(1,2,4-triazol-4-yl)phenyl)tetrazolato) dicopper(ii) Chloride, Dodecahydrate
C27H42ClCu2N21O12
CrystEngComm (2008) 10, 9 1216
a=25.822(2)Å b=7.7119(7)Å c=25.1892(19)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate 4:5 Complex with Pyridazino(4,5- d)pyridazine
(C30H20Ag4N20),4(ClO4)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0076(10)Å b=17.0076(10)Å c=7.8591(5)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Trifluorometanesulfonate Complex with Pyridazino(4,5-d)pyridazine, Solvate with 0.33 Water
C18H14Ag3N12O,3(CF3O3S)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=15.6887(9)Å b=15.6887(9)Å c=24.4805(18)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Hexaflurosilicate Tetrafluoroborate Complex with Pyridazino(4,5-d)pyridazine Hydrate
2(C15H10Ag2N10),F6Si,2(BF4),4(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0801(11)Å b=17.0782(11)Å c=7.5920(7)Å
α=90.00° β=90.00° γ=90.00°
Bis(mu-3-hydroxotricopper(ii)) heptakis(4,4'-bi(1,2,4- triazole)) Decabromide Hexahydrate
C28H42Br10Cu6N42O8
Dalton transactions (Cambridge, England : 2003) (2006) 31 3772-3776
a=11.9996(11)Å b=21.0665(17)Å c=15.6477(17)Å
α=90.00° β=109.555(11)° γ=90.00°
Bis(mu-3-hydroxotricopper(ii)) heptakis(4,4'-bi(1,2,4- triazole)) Decahloride Octahydrate
C28H46Cl10Cu6N42O10
Dalton transactions (Cambridge, England : 2003) (2006) 31 3772-3776
a=21.3590(19)Å b=12.0195(8)Å c=28.954(2)Å
α=90.00° β=97.896(10)° γ=90.00°
Hexachloro Dihydroxo Tetraaqua mu-3-Hydroxotricopper(ii) mu-3- Oxotricopper(ii) Complex with 4,4'-(1,2,4-bitriazole), Chloride Semihydrate
C12H24Cl7Cu6N18O8.5
Dalton transactions (Cambridge, England : 2003) (2006) 31 3772-3776
a=30.0968(12)Å b=30.0968(12)Å c=30.0968(12)Å
α=90.00° β=90.00° γ=90.00°
C120H234Cu18I27N6O54Rb9
C120H234Cu18I27N6O54Rb9
Journal of the Chemical Society, Dalton Transactions (2000) 13 2175
a=28.0474(6)Å b=28.0474(6)Å c=28.0474(6)Å
α=90.00° β=90.00° γ=90.00°
C26H51Cu4I6NO12Rb2
C26H51Cu4I6NO12Rb2
Journal of the Chemical Society, Dalton Transactions (2000) 13 2175
a=31.099(6)Å b=10.908(2)Å c=14.867(3)Å
α=90.00° β=90.00° γ=90.00°
C12H24BrCu3I3O6Rb
C12H24BrCu3I3O6Rb
Journal of the Chemical Society, Dalton Transactions (2000) 13 2175
a=7.954(2)Å b=24.316(5)Å c=25.291(4)Å
α=90.00° β=90.00° γ=90.00°
C15H24Cu2N3O6RbS3
C15H24Cu2N3O6RbS3
Journal of the Chemical Society, Dalton Transactions (2000) 13 2175
a=10.624(2)Å b=10.862(2)Å c=11.206(2)Å
α=84.36(3)° β=75.44(3)° γ=77.33(3)°
Bis-(4-ammoniobutyrato-O,O')pentachloro-aquadirhenium(iii) chloride, dihydrate
C8H20Cl5N2O5Re2,2(H2O),Cl
Dalton Transactions (2009) 26 5132-5136
a=9.2599(5)Å b=12.7434(6)Å c=19.1876(10)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(NO3)
Dalton Transactions (2009) 15 2856-2864
a=7.7351(7)Å b=10.8172(8)Å c=7.1540(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(ClO4)
Dalton Transactions (2009) 15 2856-2864
a=8.4650(7)Å b=10.4250(11)Å c=7.7750(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
(C4H6N4),2Ag,2(NO3)
Dalton Transactions (2009) 15 2856-2864
a=9.0359(8)Å b=13.2071(13)Å c=8.7513(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine, Dihydrate
(C4H6N4),2Ag,2(ClO4),2(H2O)
Dalton Transactions (2009) 15 2856-2864
a=6.7481(8)Å b=7.9981(9)Å c=8.1382(10)Å
α=65.302(11)° β=65.663(10)° γ=66.151(11)°
Copper(i) chloride 4:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
C4H6N4,4(CuCl)
Dalton Transactions (2009) 15 2856-2864
a=6.8143(9)Å b=6.2582(8)Å c=13.6220(17)Å
α=90.00° β=98.907(4)° γ=90.00°
Silver(i) Triflate 3:1 complex with 2,6-dimethyl-1,2,4,5- tetrazine, dihydrate
2(C4H6N4),6Ag,6(CF3O3S),4(H2O)
Dalton Transactions (2009) 15 2856-2864
a=10.5847(9)Å b=19.0579(13)Å c=23.1327(14)Å
α=90.00° β=102.038(10)° γ=90.00°
Copper(ii) acetate 2:1 complex with 4,4'-Bipyridazine, Dihydrate
C8H9CuN2O4,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=7.4144(9)Å b=8.2275(9)Å c=10.9023(13)Å
α=76.965(14)° β=82.505(13)° γ=63.267(13)°
Zinc(ii) Nitrate 1:1 Complex with 4,4'-Bipyridazine
C8H6N6O6Zn
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.07500(10)Å b=16.9431(3)Å c=11.9592(2)Å
α=90.00° β=101.3800(10)° γ=90.00°
Copper(ii) Dithionate 1:2 Complex with 4,4'-Bipyridazine, Dihydrate
C16H16CuN8O2,O6S2
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.1065(13)Å b=11.8885(9)Å c=11.0631(10)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Trifluoroacetate 2:3 Complex with 4,4'-Bipyridazine
C32H18CU2F12N12O8
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.4940(6)Å b=10.9798(8)Å c=18.3058(13)Å
α=90.00° β=98.572(5)° γ=90.00°
Copper(ii) Tetrafluoroborate 1:2 Complex with 4,4'- Bipyridazine, Solvate with 3.33 Water
C48H36Cu3N24O4,6(BF4),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=12.0861(8)Å b=14.6555(8)Å c=21.5673(15)Å
α=90.00° β=104.025(8)° γ=90.00°
Dihydroxotricopper(ii) Trifluoroacetate Complex with 4,4'- Bipyridazine, Tetrahydrate
(C28H24Cu3F6N12O8),2(C2F3O2),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.4234(9)Å b=15.7761(12)Å c=19.1034(12)Å
α=90.00° β=108.591(6)° γ=90.00°
Copper(i) Chloride 2:1 Complex with 4,4'-Bipyridazine
C8H6CL2CU2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.617(2)Å b=13.132(4)Å c=6.642(2)Å
α=90.00° β=114.23(2)° γ=90.00°
Copper(i) Bromide 2:1 Complex with 4,4'-Bipyridazine
C8H6Br2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.712(2)Å b=13.450(4)Å c=6.807(3)Å
α=90.00° β=112.79(3)° γ=90.00°
Copper(i) Iodide 2:1 Complex with 4,4'-Bipyridazine
C8H6Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.1405(5)Å b=10.1405(5)Å c=11.9784(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Hexafluorosilicate 2:3 Complex with Pyridazino(4,5- d)pyridazine, Decahydrate
C18H20Ag4N12O4,2(F6Si),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.85070(10)Å b=17.2093(3)Å c=12.0859(2)Å
α=90.00° β=100.7850(10)° γ=90.00°
Silver(i) Trifluoroacetate Complex with Pyridazino(4,5- d)pyridazine
C8H4AgF3N4O2
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.3514(2)Å b=12.5897(3)Å c=11.3054(3)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Pentafluoropropionate 2:1 Complex with Pyridazino(4,5-d)pyridazine
C12H4Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=25.2810(10)Å b=25.2810(10)Å c=7.4007(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Hexafluorosilicate 2:3 Complex with 4,4'- Bipyridazine, Trihydrate
C24H22Ag4N12O2,2(F6Si),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.7384(2)Å b=38.1690(8)Å c=50.8067(10)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Tetrafluoroborate 4:3 Complex with 4,4'- Bipyridazine Hydrate
(C24H18Ag4N12),4(BF4),(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=10.6823(8)Å b=12.1323(7)Å c=14.6844(9)Å
α=90.00° β=97.017(8)° γ=90.00°
Silver(i) Trifluoromethylsulfonate Complex with 4,4'- Bipyridazine, Solvate with 2/3 Water
C24H20Ag3N12O,3(CF3O3S),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.7652(6)Å b=22.1004(15)Å c=10.4417(7)Å
α=90.00° β=91.8740(10)° γ=90.00°
Silver(i) Heptafluorobutyrate 2:1 Complex with 4,4'- Bipyridazine
C16H6Ag2F14N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=28.4273(11)Å b=28.4273(11)Å c=7.5353(3)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Pentafluoropropionate 2:1 Complex with 4,4'- Bipyridazine
C14H6Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=26.9862(12)Å b=26.9862(12)Å c=7.6176(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Trifluoroacetate 2:1 Complex with 4,4'- Bipyridazine, Solvate with 2/7 Chloroform
C84H42Ag14F42N28O28,2(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=13.9023(2)Å b=14.4405(3)Å c=18.2666(2)Å
α=107.0790(10)° β=111.5920(10)° γ=94.2320(10)°
1,4-Dinitro-1,3-pentadiene
C5H6N2O4
CrystEngComm (2017) 19, 14 1933
a=6.0360(7)Å b=10.7787(8)Å c=10.9735(10)Å
α=90.00° β=94.546(10)° γ=90.00°
1,4-Dinitro-1,3-butadiene 1,4-Dioxane (1/1) solvate
C4H4N2O4,C4H8O2
CrystEngComm (2017) 19, 14 1933
a=8.3219(7)Å b=5.2142(4)Å c=12.3799(13)Å
α=90.00° β=90.819(12)° γ=90.00°
2,4-Dinitro-2,4-hexadiene
C6H8N2O4
CrystEngComm (2017) 19, 14 1933
a=5.4312(8)Å b=6.1004(10)Å c=12.3902(13)Å
α=90.00° β=101.006(5)° γ=90.00°
1,4-Dinitro-1,3-butadiene
C4H4N2O4
CrystEngComm (2017) 19, 14 1933
a=3.8306(3)Å b=10.3433(6)Å c=7.9532(6)Å
α=90.00° β=102.516(6)° γ=90.00°
3,5,3'-Trinitro-4,4'-bipyrazole
C6H3N7O6
New Journal of Chemistry (2018)
a=8.6064(8)Å b=11.9636(9)Å c=10.1200(9)Å
α=90° β=114.148(10)° γ=90°
Silver(I) Benzoate 2:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C28H24Ag2N4O6
New Journal of Chemistry (2008) 32, 11 1910
a=7.2863(3)Å b=14.3867(6)Å c=12.2774(5)Å
α=90.00° β=90.945(3)° γ=90.00°
Silver(I) Pentafluoropropionate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene
C17H10AgF5N4O2
New Journal of Chemistry (2008) 32, 11 1910
a=5.5566(7)Å b=10.5875(13)Å c=15.419(2)Å
α=72.987(10)° β=84.721(11)° γ=82.058(11)°
Dihydroxo Tricopper(ii) Sulfate Complex with 1,4-bi(1,2,4- triazol-4-yl)benzene, Dihydrate
C10H14Cu3N6O12S2
CrystEngComm (2008) 10, 9 1216
a=5.1275(4)Å b=16.3726(11)Å c=10.8005(9)Å
α=90.00° β=99.531(10)° γ=90.00°
Catena-poly-[bis-μ~4~-(((adamantane-1,3-diyl)—–di-(phen-4-yl))-di-(carboxylato-κO:κO))—–bis-N,N-dimethylformamide-κO-dimanganese(II)]
C24H22O42,Mn2,C3H7NO
CrystEngComm (2017) 19, 5 776
a=12.5159(10)Å b=19.1864(14)Å c=9.9596(8)Å
α=90° β=94.649(3)° γ=90°
Catena-[ bis(dimethylammonium) μ~8~-(((adamantane-1,3,5,7-tetrayl)—–tetra-(phen-4-yl))-tetracarboxylato)-manganese(II)]solvate with dimethylformamide and water
C38H28O8,Mn#afterSQUEEZE#Or#C38H28O84,Mn2,2(NC2H8),3(C3H7NO),4(H2O)#asdeterminedbyTGAelementalanalysisandin#accordancewiththeelectroneutralityofthecompound
CrystEngComm (2017) 19, 5 776
a=17.335(3)Å b=17.748(2)Å c=19.551(3)Å
α=90° β=90° γ=90°
Tetrakis-[2-((2-oxidoethylimino)methyl)phenolate]-tris(methanol)-tricopper(II) manganese(III) Triiodide
C39H48Cu3MnN4O11,I3
Dalton Trans. (2017)
a=13.3737(11)Å b=15.6103(8)Å c=23.0857(18)Å
α=90° β=92.535(9)° γ=90°
Bis-[Tetrakis-[2-((2-oxidoethylimino)methyl)phenolate]-tris(methanol)- tricopper(II) manganese(III)] Tetraisothiocyanatomanganate(II) Dimethanol solvate
2(C39H48Cu3MnN4O11),C4MnN4S4,2(CH4O)
Dalton Trans. (2017)
a=13.5453(4)Å b=15.1781(4)Å c=26.9837(9)Å
α=90.892(2)° β=103.293(2)° γ=114.678(2)°
C39H50Cu3MnN4O12,CNS,(H2O)
C39H50Cu3MnN4O12,CNS,(H2O)
Dalton Trans. (2017)
a=18.5500(12)Å b=12.9260(8)Å c=19.8784(14)Å
α=90° β=98.170(10)° γ=90°
Br,C37H44Cu3MnN4O11,H2O
Br,C37H44Cu3MnN4O11,H2O
Dalton Trans. (2017)
a=17.9628(14)Å b=13.0651(9)Å c=19.7336(14)Å
α=90° β=96.001(7)° γ=90°
C36H36Cu3MnN4O8,4(H2O),BF4
C36H36Cu3MnN4O8,4(H2O),BF4
Dalton Trans. (2017)
a=16.8093(9)Å b=13.6009(7)Å c=19.1235(10)Å
α=90° β=93.479(5)° γ=90°
Cobalt(I) Chloride 1:2 Complex with Beryllium 3-(4-Pyridyl)-2,4-pentanedionate, monohydrate
C40H42Be2Cl2CoN4O9
Dalton Transactions (2003) 9 1707
a=27.473(2)Å b=11.2165(5)Å c=13.7859(10)Å
α=90.00° β=103.000(8)° γ=90.00°
Beryllium 3-(4-Pyridyl)-2,4-pentanedionate, Methanol Solvate
C21H24BeN2O5
Dalton Transactions (2003) 9 1707
a=9.6272(3)Å b=10.6028(3)Å c=11.3100(5)Å
α=94.020(2)° β=114.8270(10)° γ=102.1680(10)°
Copper(I) Bromide Complex with Beryllium 3-(Pyridyl-4)-2,4-Pentanedionate, Solvate with Chloroform
C45.33H45.33Be2Br2Cl16Cu2N4O8
Dalton Transactions (2003) 9 1707
a=21.0193(9)Å b=25.1798(11)Å c=21.7707(9)Å
α=90.00° β=118.6180(10)° γ=90.00°
Copper(I) Copper(II) Bromide Complex with Beryllium 3-(4-Pyridyl)-2,4-pentanedionate
C40H40Be2Br3Cu2N4O8
Dalton Transactions (2003) 9 1707
a=27.199(3)Å b=11.0752(10)Å c=14.516(2)Å
α=90.00° β=102.649(2)° γ=90.00°
Cobalt(II) Acetate Benzoate 3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl, bis(Bromobenzene) clathrate
C31H32Br2CoN4O4
Journal of the Chemical Society, Dalton Transactions (2001) 6 893
a=14.1437(10)Å b=14.4751(11)Å c=16.4467(12)Å
α=90.00° β=97.7330(10)° γ=90.00°
Cobalt(II) Benzoate bis(3,3',5,5'-Tetramethyl-4,4'-bipyrazolyl), bis(Bromobenzene) clathrate
C46H48Br2CoN8O4
Journal of the Chemical Society, Dalton Transactions (2001) 6 893
a=22.3175(7)Å b=22.3175(7)Å c=21.0429(10)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Bromide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline, dichloromethane solvate
C13H14Br2Cl2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=17.7304(19)Å b=17.7304(19)Å c=12.6008(11)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Iodide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline
C12H12Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=12.3475(10)Å b=12.3475(10)Å c=13.2122(12)Å
α=90.00° β=90.00° γ=90.00°
Copper(i) Bromide 2:1 Complex with 1,2,3,6,7,8-Hexahydro- cinnolino(5,4,3-cde)cinnoline
C12H12Br2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2004) 8 1153-1158
a=12.3176(11)Å b=12.3176(11)Å c=12.772(2)Å
α=90.00° β=90.00° γ=90.00°